TechCN

Sequana Medical announces positive results from CHIHUAHUA,

PRESS RELEASE Phase 1 clinical trial (CHIHUAHUA) demonstrates that single dose of second-generation DSR product (DSR 2.0) is safe and well-tolerated,......